Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential TACE and Neoadjuvant Chemotherapy in Unresectable Colorectal Cancer
NCT05340231Phase 2Not yet recruiting
- Start
- May 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of raltitrexed in colorectal cancer (CRC). Planned start May 2022; status: not yet recruiting.
02
Drugs
raltitrexed
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05340231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05340231.